Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

NCT05139121 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1319

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: MR-100A-01

Sponsor

Mylan Technologies Inc.

Collaborators

[object Object]